NYLIM
CRL icon

New York Life Investment Management’s Charles River Laboratories CRL Stock Holding History

New York Life Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96M Buy
13,051
+482
+4% +$85.8K 0.02% 476
2026
Q1 		$2.17M Buy
12,569
+1,432
+13% +$266K 0.02% 530
2025
Q4 		$2.22M Sell
11,137
-409
-4% -$74.2K 0.02% 514
2025
Q3 		$1.81M Sell
11,546
-160
-1% -$25.4K 0.02% 561
2025
Q2 		$1.78M Sell
11,706
-480
-4% -$64K 0.02% 552
2025
Q1 		$1.83M Buy
12,186
+48
+0.4% +$8.05K 0.02% 556
2024
Q4 		$2.24M Sell
12,138
-926
-7% -$178K 0.02% 526
2024
Q3 		$2.57M Sell
13,064
-496
-4% -$103K 0.03% 515
2024
Q2 		$2.8M Buy
13,560
+1,361
+11% +$308K 0.03% 469
2024
Q1 		$3.31M Buy
12,199
+5,066
+71% +$1.21M 0.03% 433
2023
Q4 		$1.69M Sell
7,133
-5,554
-44% -$1.09M 0.02% 573
2023
Q3 		$2.49M Buy
12,687
+2,909
+30% +$597K 0.03% 462
2023
Q2 		$2.06M Buy
9,778
+2,564
+36% +$510K 0.02% 504
2023
Q1 		$1.46M Buy
7,214
+19
+0.3% +$4.31K 0.02% 564
2022
Q4 		$1.57M Buy
7,195
+11
+0.2% +$2.4K 0.02% 558
2022
Q3 		$1.41M Buy
7,184
+27
+0.4% +$5.83K 0.02% 572
2022
Q2 		$1.53M Buy
+7,157
New +$1.75M 0.02% 556

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

New York Life Investment Management's CRL Position: Q2 2026 in Review

New York Life Investment Management increased its Charles River Laboratories (CRL) stake by 3.8% in Q2 2026, buying an estimated $85.8K and bringing the position to 13,051 shares worth $2.96M. The position accounts for 0.02% of the portfolio, ranked #476.

New York Life Investment Management first reported a position in CRL in Q2 2022 and has held it in 17 quarters since. The position peaked at $3.31M in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • New York Life Investment Management held 13,051 shares of Charles River Laboratories worth $2.96M as of Q2 2026.
  • New York Life Investment Management bought 482 Charles River Laboratories shares in Q2 2026, an estimated $85.8K.
  • Charles River Laboratories made up 0.02% of New York Life Investment Management's portfolio in Q2 2026, its #476 holding.
  • New York Life Investment Management first reported a position in Charles River Laboratories in Q2 2022 and has held it in 17 quarters since.
  • New York Life Investment Management's Charles River Laboratories position peaked at $3.31M in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.